| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Cognitive Clarity Inc., developers of the Percepta®, line of plant-based nootropics targeting brain plaques and tangles in the normal aging brain, today announced that its NSF-certified product,...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that a review of the...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
New Zealand-based developer Ubiquitome will be exhibiting at the 2019 BIO International Convention in Philadelphia from 3 – 6 June. This event attracts 16,000+ attendees from over 7,000...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that preliminary results from the dose escalation part of the phase 1 study with U3-1402, an investigational and potential...
